This company provides digital health solutions focused on improving patient outcomes through technology integration. They offer platforms designed to streamline clinical workflows and enhance data management for healthcare providers. The core value lies in delivering accessible, secure tools that support modern medical practice efficiency.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional disease detection methods often rely on invasive procedures or expensive laboratory tests, limiting accessibility and hindering early diagnosis. The need for non-invasive, rapid, and cost-effective diagnostic tools remains unmet, particularly for widespread screening and preventative care.
Solution
ChromX Health is developing a breath analysis platform that identifies disease biomarkers through the detection of volatile organic compounds (VOCs) in exhaled breath. This non-invasive approach offers a convenient and accessible alternative to conventional diagnostic methods. By analyzing the unique VOC profiles associated with specific diseases, ChromX Health aims to provide rapid screening solutions that facilitate early disease detection and improve patient outcomes. The technology has the potential to transform preventative care by enabling widespread and frequent monitoring of individual health status.
Target Audience
The primary target audience includes healthcare providers, hospitals, and wellness clinics seeking non-invasive diagnostic tools for early disease detection and preventative care.
Features
- Breath collection device for capturing exhaled breath samples
- Proprietary sensor technology for detecting and quantifying VOCs
- Machine learning algorithms for analyzing VOC profiles and identifying disease biomarkers
- Cloud-based platform for data storage, analysis, and reporting
- Integration with electronic health records (EHRs) for seamless data transfer